These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38816586)

  • 41. Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) taskforce.
    Marx W; Manger SH; Blencowe M; Murray G; Ho FY; Lawn S; Blumenthal JA; Schuch F; Stubbs B; Ruusunen A; Desyibelew HD; Dinan TG; Jacka F; Ravindran A; Berk M; O'Neil A
    World J Biol Psychiatry; 2023 Jun; 24(5):333-386. PubMed ID: 36202135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis.
    Guerrera CS; Platania GA; Boccaccio FM; Sarti P; Varrasi S; Colliva C; Grasso M; De Vivo S; Cavallaro D; Tascedda F; Pirrone C; Drago F; Di Nuovo S; Blom JMC; Caraci F; Castellano S
    BMC Psychiatry; 2023 Nov; 23(1):885. PubMed ID: 38017462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetic mechanisms in mood disorders: targeting neuroplasticity.
    Fass DM; Schroeder FA; Perlis RH; Haggarty SJ
    Neuroscience; 2014 Apr; 264():112-30. PubMed ID: 23376737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments.
    Richardson B; MacPherson A; Bambico F
    Brain Behav Immun Health; 2022 Dec; 26():100554. PubMed ID: 36388140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Contribution of serotonin 5-HT
    Ibi D
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.
    Han C; Wang SM; Kato M; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2013 Jul; 13(7):851-70. PubMed ID: 23898855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of antidepressants in depression: A systematic review and meta-analysis.
    Yuan Z; Chen Z; Xue M; Zhang J; Leng L
    J Clin Neurosci; 2020 Oct; 80():169-181. PubMed ID: 33099342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options.
    Larrea A; Sánchez-Sánchez L; Diez-Martin E; Elexpe A; Torrecilla M; Astigarraga E; Barreda-Gómez G
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder.
    Su WJ; Hu T; Jiang CL
    Curr Neuropharmacol; 2024; 22(5):810-842. PubMed ID: 37559243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Digging down or scratching the surface: how patients use metaphors to describe their experiences of psychotherapy.
    Malkomsen A; Røssberg JI; Dammen T; Wilberg T; Løvgren A; Ulberg R; Evensen J
    BMC Psychiatry; 2021 Oct; 21(1):533. PubMed ID: 34706691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New insights on the role of the retina in diagnostic and therapeutic strategies in major depressive disorder.
    Cosker E; Schwan R; Angioi-Duprez K; Laprévote V; Schwitzer T
    Neurosci Biobehav Rev; 2020 Jun; 113():262-272. PubMed ID: 32147530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid-acting antidepressants targeting modulation of the glutamatergic system: clinical and preclinical evidence and mechanisms.
    Wang S; Tang S; Huang J; Chen H
    Gen Psychiatr; 2022; 35(6):e100922. PubMed ID: 36605479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews.
    Gartlehner G; Wagner G; Matyas N; Titscher V; Greimel J; Lux L; Gaynes BN; Viswanathan M; Patel S; Lohr KN
    BMJ Open; 2017 Jun; 7(6):e014912. PubMed ID: 28615268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.
    Parikh SV; Quilty LC; Ravitz P; Rosenbluth M; Pavlova B; Grigoriadis S; Velyvis V; Kennedy SH; Lam RW; MacQueen GM; Milev RV; Ravindran AV; Uher R;
    Can J Psychiatry; 2016 Sep; 61(9):524-39. PubMed ID: 27486150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implementation research for public sector mental health care scale-up (SMART-DAPPER): a sequential multiple, assignment randomized trial (SMART) of non-specialist-delivered psychotherapy and/or medication for major depressive disorder and posttraumatic stress disorder (DAPPER) integrated with outpatient care clinics at a county hospital in Kenya.
    Levy R; Mathai M; Chatterjee P; Ongeri L; Njuguna S; Onyango D; Akena D; Rota G; Otieno A; Neylan TC; Lukwata H; Kahn JG; Cohen CR; Bukusi D; Aarons GA; Burger R; Blum K; Nahum-Shani I; McCulloch CE; Meffert SM
    BMC Psychiatry; 2019 Dec; 19(1):424. PubMed ID: 31883526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beyond serotonin: newer antidepressants in the future.
    Rakesh G; Pae CU; Masand PS
    Expert Rev Neurother; 2017 Aug; 17(8):777-790. PubMed ID: 28598698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures.
    Yao H; Wang X; Chi J; Chen H; Liu Y; Yang J; Yu J; Ruan Y; Xiang X; Pi J; Xu JF
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.